Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Opioid Receptors Mnemonic | Epomedicine
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Peptide Analgesics – Opioid Peptides
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Antagonists of the kappa opioid receptor - ScienceDirect
Nephrology Journal Club on Twitter: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Structure of the human κ-opioid receptor in complex with JDTic | Nature
The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Κ-opioid receptor - an overview | ScienceDirect Topics
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Opioid Receptor | kappa, mu Opioid Receptor
